Australia excluded from US 'GENEROUS' benchmarking model that pegs prices to 'group of eight'

The U.S. government has announced a significant step in its reform of pharmaceutical pricing, introducing a new payment model that will formally link American medicine prices to those paid in a select group of comparable economies. This list notably excludes Australia and New Zealand. …